EVIDENCE ACTION INC
Organization Details
Mission Statement
EVIDENCE ACTION AIMS TO BE A WORLD LEADER IN SCALING EVIDENCE-BASED AND COST-EFFECTIVE PROGRAMS TO REDUCE THE BURDEN OF POVERTY BY BUILDING A WORLD WHERE HUNDREDS OF MILLIONS OF POOR PEOPLE HAVE BETTER OPPORTUNITIES AND THEIR LIVES ARE MEASURABLY IMPROVED. (SEE SCH. O)
Financial Information (2024)
Recent Progress (2026)
From March through July 2026, Evidence Action sustained its dual identity as both a scaled delivery machine and a rigorously evidence-driven organization. Deworm the World remained the anchor program, marking its year-midpoint with a "50/50 Pledge" while continuing to deliver treatments for under $0.50 per child; in July, Evidence Action also began actively engaging Kenya's Ministry of Education to transition the National School-Based Deworming Programme toward full government ownership. India's anaemia work showed striking longer-term gains, with the national AMB Index climbing from 38.7% to 71.2% over five years and adolescent coverage nearly quadrupling. These developments build on a period that already included a leadership transition to CEO Danielle Bayer, Zambia's syphilis screening scale-up, Nigeria's MMS policy integration, and a candid wind-down of an underperforming chlorine dispenser program.
Key Achievements
- π―Evidence Action launched its 50/50 Pledge to mark the midpoint of 2026.
- πDeworm the World protects children from parasitic worm infections for under $0.50 per child.
- π€Kenya's Ministry of Education and Evidence Action held a courtesy call to build a sustainable, government-led National School-Based Deworming Programme.
- πIndia's national Anemia Mukt Bharat Index rose from 38.7% to 71.2% over five years, with adolescent coverage nearly quadrupling.
- πEvidence Action signed a formal MOU with Madhya Pradesh's National Health Mission to strengthen Iron and Folic Acid supplementation.